Charles Russell Speechlys has promoted tax trusts & succession lawyer Alice Martin (pictured) to partner, effective May 01 2022. Zurich based Alice Martin offers UK and cross border estate planning to wealthy individuals, their families and their
Tags :cn2
CDR-Life, a Swiss biotechnology company pioneering a new and differentiated class of highly tumor-specific immune-oncology therapeutics, has completed its Series A financing raising USD 76 million. The round was led by Jeito Capital and RA Capital
TITAN Aviation Fuels, one of the largest suppliers of aviation fuel products in the United States, has acquired AKRYL, a Geneva-based aviation fuel reseller with a worldwide digital fuel procurement platform. Established in the
Christian Scalise has been promoted to legal and santion compliance manager at VTB Capital. Scalise joined VTB Capital after his experience at Sberbank as director at CIB Legal Department and at Credit Suisse as head
Alpian, a company incubated by REYL Intesa Sanpaolo, applied for a full banking licence from the SwissFinancial Market Supervisory Authority (FINMA). After a rigorous process, Alpian has become the first licensed digital private bank in
Loriot, an loT company enabling long-range networks worldwide, has signed a series A investment funding with Wika Group. This investment will accelerate the growth of the company as LoRaWAN network server provider and its expansion
Collana IT has acquired all the shares in the Swiss Neolution, a company specialized in complex web and mobile solutions with outstanding testimonials from financial institutions, insurances and companies in the field of telecommunication,
Pestalozzi appointed Fabian Martens (pictured) to the firm’s partnership. Martens will be part of the firm’s competition practice. Fabian Martens is an experienced lawyer in the field of Swiss and European competition and
Infopro Digital, a European B2B group specialised in information and technology, acquires Bindexis, a Basel based company that focuses on the monitoring and lead generation of construction projects, from NZZ. The acquisition of Bindexis
Helsinn Group (Helsinn), a fully integrated, global biopharma company with a diversified pipeline of innovative oncology assets and strong track-record of commercial execution, and BridgeBio Pharma (BridgeBio), a commercial-stage biopharmaceutical company that focuses on genetic
